Exhibitor list

Our Exhibitors

Unique Skin Ltd

Unique Skin Ltd


14513 Berlin

MT.DERM is the developer of the world's only double FDA-cleared automated microneedling medical device Class II. Our unmatched commitment to meeting the highest standards in quality, safety and innovation secures best results for wrinkle and acne scar reduction.

We are looking for a strong, reliable and well-connected cooperation partner.


Product news

  • amiea med EXCEED

    Exceed Microneedling device first to receive FDA clearance for the treatment of wrinkles and acne scarring.

    The privately-owned company, MT.DERM GmbH, Berlin, Germany, a manufacturer of medical microneedling, micropigmentation and tattoo equipment is excited to announce further expansion into the US market of its medical microneedling devices, exclusively available to healthcare professionals.

    Exceed becomes the first and only FDA-cleared microneedling device for the treatment of both acne scars (K182407) and facial wrinkles (K180778).

    “We continually seek the highest standards in respect to regulatory compliance and this is demonstrated by our ongoing expansion of our indications for use in the US market” said Jörn Kluge, Founder & CEO of MT.DERM. “Our second FDA clearance within 12 months demonstrates our desire to expand the range of indications available to our current client base and new users and I am proud that we are the first microneedling device to offer both of the major indications for facial wrinkles and acne scars.

    Marketing authorization for acne scarring was supported by an extensive clinical study.

    The study evaluated the efficacy and safety of the Exceed microneedling device when used for the treatment of acne scars in subjects 18 – 62 years of age. Fifty-six subjects were treated with four microneedling sessions 30 days apart Subjects were assessed for changes in acne scarring using an internationally recognized acne grading scale.

    The study demonstrated a statistically significant improvement in facial acne scarring, with 85% of subjects exhibiting a visible improvement in their facial acne scars at the end of the study. No subject’s acne scarring worsened. When questioned, 86% of subjects noticed a visible improvement in their acne scars compared to the start of the study, with 88% of subjects suggesting they would recommend the treatment to family and friends.